RUNX1 and T-cell non-Hodgkin lymphoma: The carcinogenic properties of RUNX1 in the absence of p53 were first presented in a study showing that the deletion of RUNX1 inhibited the development of T-cell lymphoma and extended their lifespan in p53-deficient mice [41].